Fucoidan-coated nanoparticles target radiation-induced P-selectin to enhance chemoradiotherapy in murine colorectal cancer
- 21 November 2020
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 500, 208-219
Abstract
No abstract availableKeywords
Funding Information
- Oregon State University
- National Institutes of Health (1R35GM119839-01)
This publication has 44 references indexed in Scilit:
- Targeting P-Selectin by Gallium-68–Labeled Fucoidan Positron Emission Tomography for Noninvasive Characterization of Vulnerable PlaquesArteriosclerosis, Thrombosis, and Vascular Biology, 2014
- Rationale for Poly(ADP-ribose) Polymerase (PARP) Inhibitors in Combination Therapy with Camptothecins or Temozolomide Based on PARP Trapping versus Catalytic InhibitionThe Journal of Pharmacology and Experimental Therapeutics, 2014
- Materials innovation for co-delivery of diverse therapeutic cargosRSC Advances, 2013
- Nanoscale metal–organic materialsChemical Society Reviews, 2010
- Radiation-Guided Drug Delivery to Mouse Models of Lung CancerClinical Cancer Research, 2010
- Endocytosis of nanomedicinesJournal of Controlled Release, 2010
- Poly(ADP-ribose) polymerase inhibitor ABT-888 potentiates the cytotoxic activity of temozolomide in leukemia cells: influence of mismatch repair status andO6-methylguanine-DNA methyltransferase activityMolecular Cancer Therapeutics, 2009
- Affinity of low molecular weight fucoidan for P-selectin triggers its binding to activated human plateletsBiochimica et Biophysica Acta (BBA) - General Subjects, 2009
- ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor ModelsClinical Cancer Research, 2007
- Role of P‐selectin in radiation‐induced intestinal inflammatory damageInternational Journal of Cancer, 2001